132 related articles for article (PubMed ID: 33058028)
1. circRNA circ-MYBL2 is a novel tumor suppressor and potential biomarker in multiple myeloma.
Yu S; Ai L; Wei W; Pan J
Hum Cell; 2021 Jan; 34(1):219-228. PubMed ID: 33058028
[TBL] [Abstract][Full Text] [Related]
2. Circ_0006332 promotes growth and progression of bladder cancer by modulating MYBL2 expression via miR-143.
Li M; Liu Y; Liu J; Li W; Li N; Xue D; Zhang X; Wang P
Aging (Albany NY); 2019 Nov; 11(22):10626-10643. PubMed ID: 31756170
[TBL] [Abstract][Full Text] [Related]
3. CircRNA circ-MYBL2 absorbs precursor miR-92b in the nucleus to suppress its role in enhancing gastric cancer cell proliferation.
Luo R
Am J Med Sci; 2022 Oct; 364(4):454-460. PubMed ID: 35644224
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive profiling of circular RNA expressions reveals potential diagnostic and prognostic biomarkers in multiple myeloma.
Zhou F; Wang D; Wei W; Chen H; Shi H; Zhou N; Wu L; Peng R
BMC Cancer; 2020 Jan; 20(1):40. PubMed ID: 31948430
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway.
Shi Y; Liu C
BMC Cancer; 2021 Nov; 21(1):1249. PubMed ID: 34800978
[TBL] [Abstract][Full Text] [Related]
6. A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer.
Liu Q; Guo L; Qi H; Lou M; Wang R; Hai B; Xu K; Zhu L; Ding Y; Li C; Xie L; Shen J; Xiang X; Shao J
Cell Death Dis; 2021 Jul; 12(7):683. PubMed ID: 34234118
[TBL] [Abstract][Full Text] [Related]
7. miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4.
Li X; Jiao M; Hu J; Qi M; Zhang J; Zhao M; Liu H; Xiong X; Dong X; Han B
Prostate; 2020 Jun; 80(9):674-686. PubMed ID: 32294305
[TBL] [Abstract][Full Text] [Related]
8. CircRNA circ_0001821 predicts an unfavorable prognosis and promotes the proliferation of multiple myeloma.
Liu L; Zhang F; Li J
Hematology; 2021 Dec; 26(1):716-723. PubMed ID: 34555307
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA circFAT1(e2) Facilitates Cell Progression through the miR-30e-5P/MYBL2 Pathway in Glioma.
Liu Z; Guo S; Yan D; Bai Y; Song Z; Liu X
Dis Markers; 2023; 2023():7418365. PubMed ID: 36776924
[TBL] [Abstract][Full Text] [Related]
10. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.
Xiong YC; Wang J; Cheng Y; Zhang XY; Ye XQ
Mol Cell Biochem; 2020 May; 468(1-2):185-193. PubMed ID: 32200471
[TBL] [Abstract][Full Text] [Related]
12. MM-associated circular RNA downregulates microRNA-19a through methylation to suppress proliferation of pancreatic adenocarcinoma cells.
Qian X; Zong W; Ma L; Yang Z; Chen W; Yan J; Xu J
Bioengineered; 2022 Apr; 13(4):9294-9300. PubMed ID: 35387554
[TBL] [Abstract][Full Text] [Related]
13. The novel circular RNA circ-PGAP3 retards cervical cancer growth by regulating the miR-769-5p/p53 axis.
Jun T; Chen W; Hailing C; Ning W; Qinxue C
Hum Cell; 2021 May; 34(3):878-888. PubMed ID: 33591461
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circ-CDYL sponges miR-1180 to elevate yes-associated protein in multiple myeloma.
Chen F; Wang X; Fu S; Wang S; Fu Y; Zhang J; Liu Z
Exp Biol Med (Maywood); 2020 Jun; 245(11):925-932. PubMed ID: 32321304
[TBL] [Abstract][Full Text] [Related]
15. CircRNA circ_0000190 inhibits the progression of multiple myeloma through modulating miR-767-5p/MAPK4 pathway.
Feng Y; Zhang L; Wu J; Khadka B; Fang Z; Gu J; Tang B; Xiao R; Pan G; Liu J
J Exp Clin Cancer Res; 2019 Feb; 38(1):54. PubMed ID: 30728056
[TBL] [Abstract][Full Text] [Related]
16. Serum hsa_circ_0087776 as a new oncologic marker for the joint diagnosis of multiple myeloma.
Gong X; Lu X; Cao J; Liu H; Chen H; Bao F; Shi X; Cong H
Bioengineered; 2021 Dec; 12(2):12447-12459. PubMed ID: 34905439
[TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_001659 serves as a novel diagnostic and prognostic biomarker for colorectal cancer.
He B; Chao W; Huang Z; Zeng J; Yang J; Luo D; Huang S; Pan H; Hao Y
Biochem Biophys Res Commun; 2021 Apr; 551():100-106. PubMed ID: 33725570
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma.
Yu R; Li C; Lin X; Chen Q; Li J; Song L; Lin L; Liu J; Zhang Y; Kong W; Ouyang X; Chen X
Pathol Res Pract; 2017 Aug; 213(8):964-968. PubMed ID: 28559119
[TBL] [Abstract][Full Text] [Related]
19. [High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer].
Yang M; Zhu X; Shen Y; He Q; Qin Y; Shao Y; Yuan L; Ye H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1109-1118. PubMed ID: 36073208
[TBL] [Abstract][Full Text] [Related]
20. MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder Cancer.
Liang HB; Cao Y; Ma Q; Shu YJ; Wang Z; Zhang F; Ye YY; Li HF; Xiang SS; Song XL; Xu Y; Zhang YC; Bao RF; Yuan RY; Zhang YJ; Hu YP; Jiang L; Li ML; Wang XA; Wu XS; Wu WG; Zhao S; Fand Y; Cui XP; Lu YS; Zhou J; Zheng L; Gong W; Liu YB
Cell Physiol Biochem; 2017; 41(5):2117-2131. PubMed ID: 28427077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
